Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Warns Against Use of OTC Cough/Cold Products in Young Children
Link ID 2527
Title FDA Warns Against Use of OTC Cough/Cold Products in Young Children
Url http://www.medscape.com/viewarticle/568984?src=rss
Description Over-the-counter cough and cold products have not been shown to be safe or effective in children younger than age 2 years, the agency says. Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Jan 19, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Sunrise Senior Shares Fall 39 Pct After Downgrades
  Sunrise Senior Living Inc shares tumbled 39 percent on Monday after at least two analyst downgrades, citing financing concerns. Reuters Health Information
Category:   Articles > Business of Medicine


2. U.S. Medicare to Tighten Rules for Private Plans
  Companies that sell Medicare Advantage plans would have to modify sales commissions to stop salesmen from switching beneficiaries to a new plan each year to earn the highest possible fee, a U.S. government agency proposed on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine


3. A Reader and Author Respond to "Going Lean in the Emergency Department: A Strategy for Addressing Em
  A reader and author delve into the question: "What does it mean to go Lean?"
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine


4. Preventing and Controlling Emerging and Reemerging Transmissible Diseases in the Homeless
  Homelessness is a grave public health problem, and the current review examines best practices in the prevention and treatment of illness in the setting of homelessness. Emerging Infectious Diseases
Category:   Articles > Business of Medicine


5. FDA Staffer Seeks Higher Standards After Avandia Concerns
  A U.S. Food and Drug Administration official called for higher safety standards in approving diabetes drugs in the aftermath of fears about links between a top diabetes drug and heart attack risk. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS